The recent registration of AlzWIN on FDA has opened up new possibilities for improving the diagnosis and management of cognitive decline. This innovative tool, now officially recognized as a computerized cognitive assessment aid, will play a pivotal role in helping healthcare professionals identify individuals at risk for dementia. By screening for early signs of […]

The post AlzWIN’s FDA Registration Marks a Milestone in Cognitive Assessment and Dementia Care appeared first on TechBullion.